Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorKaiyrzhanov, Rauan
dc.contributor.authorOrtigoza Escobar, Juan Dario
dc.contributor.authorStringer, Brett
dc.contributor.authorGanieva, Manizha
dc.contributor.authorGowda, Vykuntaraju K
dc.contributor.authorSrinivasan, Varunvenkat M.
dc.contributor.authorMacaya Ruíz, Alfons
dc.date.accessioned2024-07-02T09:51:41Z
dc.date.available2024-07-02T09:51:41Z
dc.date.issued2024-06
dc.identifier.citationKaiyrzhanov R, Ortigoza-Escobar JD, Stringer BW, Ganieva M, Gowda VK, Srinivasan VM, et al. Clinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia. Mov Disord. 2024 Jun;39(6):983–95.
dc.identifier.issn1531-8257
dc.identifier.urihttps://hdl.handle.net/11351/11654
dc.descriptionAtaxia; Cerebellar atrophy; Vermis atrophy
dc.description.abstractBackground Based on a limited number of reported families, biallelic CA8 variants have currently been associated with a recessive neurological disorder named, cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CAMRQ-3). Objectives We aim to comprehensively investigate CA8-related disorders (CA8-RD) by reviewing existing literature and exploring neurological, neuroradiological, and molecular observations in a cohort of newly identified patients. Methods We analyzed the phenotype of 27 affected individuals from 14 families with biallelic CA8 variants (including data from 15 newly identified patients from eight families), ages 4 to 35 years. Clinical, genetic, and radiological assessments were performed, and zebrafish models with ca8 knockout were used for functional analysis. Results Patients exhibited varying degrees of neurodevelopmental disorders (NDD), along with predominantly progressive cerebellar ataxia and pyramidal signs and variable bradykinesia, dystonia, and sensory impairment. Quadrupedal gait was present in only 10 of 27 patients. Progressive selective cerebellar atrophy, predominantly affecting the superior vermis, was a key diagnostic finding in all patients. Seven novel homozygous CA8 variants were identified. Zebrafish models demonstrated impaired early neurodevelopment and motor behavior on ca8 knockout. Conclusion Our comprehensive analysis of phenotypic features indicates that CA8-RD exhibits a wide range of clinical manifestations, setting it apart from other subtypes within the category of CAMRQ. CA8-RD is characterized by cerebellar atrophy and should be recognized as part of the autosomal-recessive cerebellar ataxias associated with NDD. Notably, the presence of progressive superior vermis atrophy serves as a valuable diagnostic indicator. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesMovement Disorders;39(6)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectAtàxia - Aspectes genètics
dc.subjectFenotip
dc.subjectTrastorns del desenvolupament - Aspectes genètics
dc.subject.meshNeurodevelopmental Disorders
dc.subject.meshCerebellar Ataxia
dc.subject.mesh/genetics
dc.subject.meshPhenotype
dc.titleClinical and Molecular Spectrum of Autosomal Recessive CA8-Related Cerebellar Ataxia
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/mds.29754
dc.subject.decstrastornos del desarrollo neurológico
dc.subject.decsataxia cerebelosa
dc.subject.decs/genética
dc.subject.decsfenotipo
dc.relation.publishversionhttps://doi.org/10.1002/mds.29754
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Kaiyrzhanov R] Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom. [Ortigoza-Escobar JD] U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER), Instituto de Salud Carlos III, Barcelona, Spain. Movement Disorders Unit, Pediatric Neurology Department, Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain. European Reference Network for Rare Neurological Diseases (ERN-RND), Barcelona, Spain. [Stringer BW] Griffith Institute for Drug Discovery, Centre for Cellular Phenomics, School of Environment and Science Griffith University, Brisbane, Queensland, Australia. [Ganieva M] Avicenna Tajik State Medical University, Department of Neurology and Medical Genetics, Dushanbe, Tajikistan. [Gowda VK, Srinivasan VM] Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bangalore, India. [Macaya A] European Reference Network for Rare Neurological Diseases (ERN-RND), Barcelona, Spain. Servei de Neurologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid38581205
dc.identifier.wos001197664700001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record